Abivax Sa American Depositary Shares Stock Prediction and Forecast [ABVX]

AI-generated source summary

The analysis assesses Abivax SA American Depository Shares (ABVX) stock, reporting a buy candidate with a score of 1.880 as of September 12, 2025. Since June 25, 2025, a gain of 1091.63% has been observed, averaging a 19.49% daily return. The short-term trend is upward, with a projected change of 44973.51% over the next three months, projecting returns ranging from 38921.61% to 55510.88%. The 12-month analysis forecasts a 116.80% increase, estimating future prices between $36.67 and $196.82. Recent activity shows a 2.27% decrease to $84.01 on the last trading day, with a fluctuation of 3.08% between $82.29 and $84.82. A sell signal was issued from a pivot top on September 8, 2025, with the stock falling 6.66% since then, however, an increasing number of analysts seem to consider it as a buy candidate, or at least an overperform candidate and with a high risk rating. Support is identified at $69.76, with resistance at $85.96. A stop-loss is recommended at $79.24, a 5.68% decrease.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   13 Sept 2025, 04:13 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

4. Outcome tracking started

   19 May 2026, 02:08 UTC

   Tahlil Plus began monitoring the extracted predictions.

5. Live evaluation in progress

   01 Aug 2026, 04:53 UTC

   1 signal remains active.